Joshua K. Schaffzin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Joshua K. Schaffzin has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Felicia Scaggs Huang
Cincinnati Children’s Hospital Medical Center
6 shared publications - David Jay Weber
The University of North Carolina at Chapel Hill
3 shared publications Deborah S. Yokoe
3 shared publicationsErin Kyle
Association of PeriOperative Registered Nurses
3 shared publications- Janet Glowicz
Centers for Disease Control and Prevention, Atlanta, Georgia, United States
3 shared publications - Kavita K. Trivedi
Division of Communicable Disease Control and Prevention, Alameda County Public Health Department, San Leandro, CA, USA
3 shared publications
Latest Publications
- 27 January 2026
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 73 (2) , 445-469
Surgical Site Infections and Perioperative Antibiotic Use in Children with Medical Complexity
- 27 January 2026
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 73 (2) , 445-469
Surgical Site Infections and Perioperative Antibiotic Use in Children with Medical Complexity
- 22 December 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 47 (2) , 119-123
Commentary: navigating practice decisions when guidelines offer “no recommendation”
- 22 December 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 47 (2) , 119-123
Commentary: navigating practice decisions when guidelines offer “no recommendation”
- Open Access
- 18 November 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (12) , 1289
Multisociety guidance for sterilization and high-level disinfection – CORRIGENDUM
- 18 November 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (12) , 1289
Open AccessMultisociety guidance for sterilization and high-level disinfection – CORRIGENDUM
- 26 August 2025
- Published by Elsevier in American Journal of Infection Control
- Vol. 53 (12) , 1350-1353
Effectiveness of COVID-19 vaccination to prevent health care personnel absences: A single site experience
- 26 August 2025
- Published by Elsevier in American Journal of Infection Control
- Vol. 53 (12) , 1350-1353
Effectiveness of COVID-19 vaccination to prevent health care personnel absences: A single site experience
- Top Cited Papers
- 28 April 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (6) , 561-583
Multisociety guidance for sterilization and high-level disinfection
This multisociety infection prevention guidance document was developed for individuals and organizations that engage in sterilization or high-level disinfection (HLD). It was endorsed by SHEA, APIC, ASGE, IDSA, and SGNA. This guidance is based on a synthesis of published scientific evidence, theoretical rationale, current practices, practical considerations, writing group consensus, and consideration of potential harm when applicable. The supplementary material includes a summary of recommendations. The guidance provides an overview of the Spaulding Classification and considerations around manufacturers’ instructions for use (MIFUs). Its recommendations address: point-of-use treatment prior to sterilization or HLD, preparation of reusable medical devices at the location of processing, sterilization, and immediate use steam sterilization (IUSS), HLD of lumened and non-lumened devices, processing of reusable medical devices used with lubricating or defoaming agents, monitoring for effectiveness of processing, handling of devices after HLD, augments and alternatives to HLD, processing of investigational devices, tracking of reusable medical devices, and approaches to implementation.
- 28 April 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (6) , 561-583
Top Cited PapersMultisociety guidance for sterilization and high-level disinfection
This multisociety infection prevention guidance document was developed for individuals and organizations that engage in sterilization or high-level disinfection (HLD). It was endorsed by SHEA, APIC, ASGE, IDSA, and SGNA. This guidance is based on a synthesis of published scientific evidence, theoretical rationale, current practices, practical considerations, writing group consensus, and consideration of potential harm when applicable. The supplementary material includes a summary of recommendations. The guidance provides an overview of the Spaulding Classification and considerations around manufacturers’ instructions for use (MIFUs). Its recommendations address: point-of-use treatment prior to sterilization or HLD, preparation of reusable medical devices at the location of processing, sterilization, and immediate use steam sterilization (IUSS), HLD of lumened and non-lumened devices, processing of reusable medical devices used with lubricating or defoaming agents, monitoring for effectiveness of processing, handling of devices after HLD, augments and alternatives to HLD, processing of investigational devices, tracking of reusable medical devices, and approaches to implementation.
- Open Access
- 12 September 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e128
An outbreak after all: Cutibacterium acnes among pediatric patients with cerebrospinal fluid diversion device infections highlights gaps in guidelines
Objective: Cutibacterium acnes is normal skin flora but can cause sterile implant infections. We investigated a cluster of seven patients with C. acnes in anaerobic cerebrospinal fluid (CSF) cultures in November 2020. Further analysis identified a missed outbreak, highlighting ambiguity in diagnosis of indolent organisms in the 2017 IDSA meningitis guidelines. Design: Outbreak investigation. Setting: Quaternary pediatric facility. Patients: A case was defined as a hospitalized patient with C. acnes isolated from CSF culture from January 1, 2016 to December 31, 2022. Methods: We defined comparison periods based on timing of C. acnes culture positivity as 1) pre-outbreak (2016–2020), 2) outbreak (2020–2021), and 3) post-outbreak (2022). Rates of C. acnes positive cultures per 1000 CSF cultures and rate ratios were calculated by comparison periods. Results: We identified 9 positive C. acnes CSF cultures among 7 cases November 10–27, 2020, all with at least 1 CSF diversion device. The anaerobic culture media was substituted at the time of case cluster. In 2021, the culture media was implemented permanently with no increase in C. acnes culture positivity. The rate of C. acnes positive CSF cultures and rate ratio increased in the outbreak period (p=0.01) compared to pre-outbreak and post-outbreak periods. There was no difference between the pre- and post-outbreak periods. Conclusions: Retrospective analysis of CSF culture data led to reclassifying a C. acnes pseudo-outbreak as a true outbreak in CSF diversion devices at our institution. Clearer guidance is needed to delineate the role of C. acnes in CSF diversion device infections.
- 12 September 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e128
Open AccessAn outbreak after all: Cutibacterium acnes among pediatric patients with cerebrospinal fluid diversion device infections highlights gaps in guidelines
Objective: Cutibacterium acnes is normal skin flora but can cause sterile implant infections. We investigated a cluster of seven patients with C. acnes in anaerobic cerebrospinal fluid (CSF) cultures in November 2020. Further analysis identified a missed outbreak, highlighting ambiguity in diagnosis of indolent organisms in the 2017 IDSA meningitis guidelines. Design: Outbreak investigation. Setting: Quaternary pediatric facility. Patients: A case was defined as a hospitalized patient with C. acnes isolated from CSF culture from January 1, 2016 to December 31, 2022. Methods: We defined comparison periods based on timing of C. acnes culture positivity as 1) pre-outbreak (2016–2020), 2) outbreak (2020–2021), and 3) post-outbreak (2022). Rates of C. acnes positive cultures per 1000 CSF cultures and rate ratios were calculated by comparison periods. Results: We identified 9 positive C. acnes CSF cultures among 7 cases November 10–27, 2020, all with at least 1 CSF diversion device. The anaerobic culture media was substituted at the time of case cluster. In 2021, the culture media was implemented permanently with no increase in C. acnes culture positivity. The rate of C. acnes positive CSF cultures and rate ratio increased in the outbreak period (p=0.01) compared to pre-outbreak and post-outbreak periods. There was no difference between the pre- and post-outbreak periods. Conclusions: Retrospective analysis of CSF culture data led to reclassifying a C. acnes pseudo-outbreak as a true outbreak in CSF diversion devices at our institution. Clearer guidance is needed to delineate the role of C. acnes in CSF diversion device infections.
- Open Access
- 19 October 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (10) , 1533-1539
Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates
Since the initial publication of A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals in 2008, the prevention of healthcare-associated infections (HAIs) has continued to be a national priority. Progress in healthcare epidemiology, infection prevention, antimicrobial stewardship, and implementation science research has led to improvements in our understanding of effective strategies for HAI prevention. Despite these advances, HAIs continue to affect ∼1 of every 31 hospitalized patients,1 leading to substantial morbidity, mortality, and excess healthcare expenditures,1 and persistent gaps remain between what is recommended and what is practiced.The widespread impact of the coronavirus disease 2019 (COVID-19) pandemic on HAI outcomes2 in acute-care hospitals has further highlighted the essential role of infection prevention programs and the critical importance of prioritizing efforts that can be sustained even in the face of resource requirements from COVID-19 and future infectious diseases crises.3The Compendium: 2022 Updates document provides acute-care hospitals with up-to-date, practical expert guidance to assist in prioritizing and implementing HAI prevention efforts. It is the product of a highly collaborative effort led by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Disease Society of America (IDSA), the Association for Professionals in Infection Control and Epidemiology (APIC), the American Hospital Association (AHA), and The Joint Commission, with major contributions from representatives of organizations and societies with content expertise, including the Centers for Disease Control and Prevention (CDC), the Pediatric Infectious Disease Society (PIDS), the Society for Critical Care Medicine (SCCM), the Society for Hospital Medicine (SHM), the Surgical Infection Society (SIS), and others.
- 19 October 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (10) , 1533-1539
Open AccessIntroduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates
Since the initial publication of A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals in 2008, the prevention of healthcare-associated infections (HAIs) has continued to be a national priority. Progress in healthcare epidemiology, infection prevention, antimicrobial stewardship, and implementation science research has led to improvements in our understanding of effective strategies for HAI prevention. Despite these advances, HAIs continue to affect ∼1 of every 31 hospitalized patients,1 leading to substantial morbidity, mortality, and excess healthcare expenditures,1 and persistent gaps remain between what is recommended and what is practiced.The widespread impact of the coronavirus disease 2019 (COVID-19) pandemic on HAI outcomes2 in acute-care hospitals has further highlighted the essential role of infection prevention programs and the critical importance of prioritizing efforts that can be sustained even in the face of resource requirements from COVID-19 and future infectious diseases crises.3The Compendium: 2022 Updates document provides acute-care hospitals with up-to-date, practical expert guidance to assist in prioritizing and implementing HAI prevention efforts. It is the product of a highly collaborative effort led by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Disease Society of America (IDSA), the Association for Professionals in Infection Control and Epidemiology (APIC), the American Hospital Association (AHA), and The Joint Commission, with major contributions from representatives of organizations and societies with content expertise, including the Centers for Disease Control and Prevention (CDC), the Pediatric Infectious Disease Society (PIDS), the Society for Critical Care Medicine (SCCM), the Society for Hospital Medicine (SHM), the Surgical Infection Society (SIS), and others.
- Open Access
- 11 September 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (12) , 2096-2097
Negative-pressure rooms and Aspergillus risk—Air balance alone is insufficient
To the Editor-The recent article by Biebelberg et al 1 reported on increased healthcare-acquired (HA) aspergillosis among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive patients cared for in "negative pressure" or "modified AIIR" rooms. The conclusion was that negative air balance in a room compared to the hallway may increase risk of HA aspergillosis. There are a number of issues with this conclusion, which implies that airborne infection isolation rooms (AIIRs) may increase the risk of nosocomial disease. Biebelberg et al 1 neglected to define what they meant by a "negative pressure" or "modified AIIR" room. The term 'negative-pressure room' is often used to mean AIIR, but it addresses only 1 of 4 requirements for the latter. Guidance published for US and Canadian facilities require an AIIR to: (1) be negatively balanced to adjacent spaces; (2) provide a minimum of 12 air changes per hour (ACH); (3) provide a minimum of minimum efficiency reporting value (MERV) 14 filtration; and (4) exhaust directly to the outside. 2,3 An anteroom that is negatively balanced to the corridor and positively balanced to the AIIR with a minimum of 10 ACH is required in Canada and has been recommended based on a risk assessment in the United States. 2-4 The anteroom allows for safe donning or doffing of personal protective equipment and acts as an airlock between the adjacent space and the patient to minimize risk of exposure to contaminated aerosols. 5 The Centers for Disease Control and Prevention and Health Canada guidance for managing SARS-CoV-2-positive patients undergoing aerosol-generating procedures (AGPs) is to do so in AIIRs when available. 6,7 Modifying existing spaces to accommodate demand from a large-scale airborne infectious disease outbreak by increasing the number of AIIRs available involves managing air balance, ACH requirements, presence of anterooms, a pressure-sealed/leak-proof space and more. 2,3,8 Biebelberg et al do not describe how Brigham and Women's Hospital (BWH) created their "modified AIIR" rooms. Specifically, whether they rebalanced the rooms to be
- 11 September 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (12) , 2096-2097
Open AccessNegative-pressure rooms and Aspergillus risk—Air balance alone is insufficient
To the Editor-The recent article by Biebelberg et al 1 reported on increased healthcare-acquired (HA) aspergillosis among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive patients cared for in "negative pressure" or "modified AIIR" rooms. The conclusion was that negative air balance in a room compared to the hallway may increase risk of HA aspergillosis. There are a number of issues with this conclusion, which implies that airborne infection isolation rooms (AIIRs) may increase the risk of nosocomial disease. Biebelberg et al 1 neglected to define what they meant by a "negative pressure" or "modified AIIR" room. The term 'negative-pressure room' is often used to mean AIIR, but it addresses only 1 of 4 requirements for the latter. Guidance published for US and Canadian facilities require an AIIR to: (1) be negatively balanced to adjacent spaces; (2) provide a minimum of 12 air changes per hour (ACH); (3) provide a minimum of minimum efficiency reporting value (MERV) 14 filtration; and (4) exhaust directly to the outside. 2,3 An anteroom that is negatively balanced to the corridor and positively balanced to the AIIR with a minimum of 10 ACH is required in Canada and has been recommended based on a risk assessment in the United States. 2-4 The anteroom allows for safe donning or doffing of personal protective equipment and acts as an airlock between the adjacent space and the patient to minimize risk of exposure to contaminated aerosols. 5 The Centers for Disease Control and Prevention and Health Canada guidance for managing SARS-CoV-2-positive patients undergoing aerosol-generating procedures (AGPs) is to do so in AIIRs when available. 6,7 Modifying existing spaces to accommodate demand from a large-scale airborne infectious disease outbreak by increasing the number of AIIRs available involves managing air balance, ACH requirements, presence of anterooms, a pressure-sealed/leak-proof space and more. 2,3,8 Biebelberg et al do not describe how Brigham and Women's Hospital (BWH) created their "modified AIIR" rooms. Specifically, whether they rebalanced the rooms to be
- Open Access
- 22 August 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (10) , 1540-1554
Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates
- 22 August 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (10) , 1540-1554
Open AccessExecutive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates
- Open Access
- 11 July 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (8) , 1232-1246
Implementing strategies to prevent infections in acute-care settings
This document introduces and explains common implementation concepts and frameworks relevant to healthcare epidemiology and infection prevention and control and can serve as a stand-alone guide or be paired with the “SHEA/IDSA/APIC Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2022 Updates,” which contain technical implementation guidance for specific healthcare-associated infections. This Compendium article focuses on broad behavioral and socio-adaptive concepts and suggests ways that infection prevention and control teams, healthcare epidemiologists, infection preventionists, and specialty groups may utilize them to deliver high-quality care. Implementation concepts, frameworks, and models can help bridge the “knowing-doing” gap, a term used to describe why practices in healthcare may diverge from those recommended according to evidence. It aims to guide the reader to think about implementation and to find resources suited for a specific setting and circumstances by describing strategies for implementation, including determinants and measurement, as well as the conceptual models and frameworks: 4Es, Behavior Change Wheel, CUSP, European and Mixed Methods, Getting to Outcomes, Model for Improvement, RE-AIM, REP, and Theoretical Domains.
- 11 July 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (8) , 1232-1246
Open AccessImplementing strategies to prevent infections in acute-care settings
This document introduces and explains common implementation concepts and frameworks relevant to healthcare epidemiology and infection prevention and control and can serve as a stand-alone guide or be paired with the “SHEA/IDSA/APIC Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2022 Updates,” which contain technical implementation guidance for specific healthcare-associated infections. This Compendium article focuses on broad behavioral and socio-adaptive concepts and suggests ways that infection prevention and control teams, healthcare epidemiologists, infection preventionists, and specialty groups may utilize them to deliver high-quality care. Implementation concepts, frameworks, and models can help bridge the “knowing-doing” gap, a term used to describe why practices in healthcare may diverge from those recommended according to evidence. It aims to guide the reader to think about implementation and to find resources suited for a specific setting and circumstances by describing strategies for implementation, including determinants and measurement, as well as the conceptual models and frameworks: 4Es, Behavior Change Wheel, CUSP, European and Mixed Methods, Getting to Outcomes, Model for Improvement, RE-AIM, REP, and Theoretical Domains.